无内镜辅助腋窝入路乳房切除术用于胸部男性化手术
该研究评估了一种新型无内镜辅助腋窝入路乳房切除术,用于Fisher 1、2A及部分2B分型的性别烦躁患者。患者BODY-Q满意度统计上非常高,该术式优先减少瘢痕,为东亚患者提供有价值的手术替代方案。
要点
- 无内镜辅助腋窝入路乳房切除术可减少乳晕瘢痕,适用于Fisher 1、2A及部分2B患者。
- 总并发症率45.8%,以可逆性乳头乳晕浅表皮肤坏死为主(20.8%)。
- 严重并发症罕见:乳头乳晕复合体全坏死2.0%,急性血肿2.0%。
核心结论
- 无内镜辅助腋窝入路乳房切除术优先实现最小瘢痕,在严格筛选的患者队列中患者满意度高且严重并发症率低。
研究设计与样本
- 本研究纳入Fisher 1、2A及部分2B分型患者,经腋窝切口行无内镜辅助乳房切除术,通过并发症率和BODY-Q问卷(评分0-100)评估结局。
主要发现
- 总并发症率为45.8%(22/48),以可逆性乳头乳晕浅表皮肤坏死为主(20.8%)。
- 严重并发症罕见:乳头乳晕复合体全坏死2.0%(1/48),急性血肿2.0%(1/48)。
- 患者BODY-Q满意度统计上非常高。
临床怎么用
- 对于Fisher 1、2A及部分2B分型且关注瘢痕的性别烦躁患者,可考虑无内镜辅助腋窝入路乳房切除术作为手术替代方案。
局限性
- 证据等级为4级(治疗性)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: For gender-affirming mastectomy in patients with gender dysphoria and small/nonptotic breasts, traditional periareolar techniques carry risks of visible scar complications. A scar-minimizing alternative is needed. OBJECTIVES: The aim of the study was to evaluate the outcomes of a novel nonendoscopic axillary approach mastectomy, aiming to eliminate areolar scars or diminish circumareolar incision while assessing safety and patient satisfaction. METHODS: This study included patients classified with Fisher 1, 2A, and a portion of 2B patients. Mastectomy was performed through an axillary incision without endoscopic assistance. Outcomes were evaluated through complication rates and patient-reported outcomes using the BODY-Q questionnaire (score 0-100). RESULTS: From December 2020 to August 2024, 48 patients (average age 33.65) underwent the procedure. The average operative time was 167.1 min. The overall complication rate was 45.8% (22/48), predominantly minor, reversible nipple-areola superficial skin necrosis (20.8%). Severe complications were rare: total NAC necrosis 2.0% (1/48) and acute hematoma 2.0% (1/48). Patient satisfaction on the BODY-Q scale was statistically very high. CONCLUSIONS: This axillary approach for mastectomy successfully prioritizes minimal scarring, a key aesthetic concern particularly for East Asian patients. In a carefully selected cohort, it achieves high patient satisfaction with a low rate of severe complications, offering a valuable surgical alternative. LEVEL OF EVIDENCE: 4 (THERAPEUTIC): For image description, please refer to the figure legend and surrounding text.
引用
- Tang X. Axillary Approach Mastectomy Without Endoscopic Assistance in Chest Masculinization Surgery. Aesthet Surg J. 2026. PMID: 41549744. doi:10.1093/asj/sjag009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。